SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently driving massive market excitement following its historic IPO, with investors focused on the stock's significant valuation and its potential to benefit from forced buying by index funds. Community discussion is split between bullish sentiment fueled by Elon Musk's long-term vision for aerospace dominance and skeptical warnings about the company's lack of current profitability.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Investors are actively debating the sustainability of the semiconductor rally as SOXL experiences heightened volatility, with community sentiment split between those viewing recent pullbacks as prime accumulation opportunities and others concerned about significant leverage decay and potential market correction. The conversation is largely centered on gauging new support levels amid shifting geopolitical narratives and the highly anticipated upcoming IPO of SpaceX, which traders are closely watching for its broader impact on market liquidity.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as the memory sector rallies on AI-driven supply constraints and rumors of a potential geopolitical peace deal, fueling community speculation about a significant price run-up before earnings. While investors debate the sustainability of record data center infrastructure spending, sentiment remains highly bullish with active discussions regarding PT upgrades, historical cyclical shifts, and institutional accumulation.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is facing significant volatility and investor frustration as market participants debate its valuation relative to the upcoming SpaceX IPO, with many questioning the fund's lack of transparency regarding management actions and recent dilution. While some investors see the current pullback as a bargain opportunity to gain exposure to a basket of high-growth tech firms including Anthropic and OpenAI, others are concerned that the fund's premium is evaporating now that direct access to its largest holdings is becoming possible.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors debate the impact of a recent capital raise against the backdrop of breakthrough Phase 3 trial data for its hereditary angioedema therapy. Community sentiment is deeply divided between long-term bulls highlighting the potential for a commercialized gene-editing cure and skeptical traders concerned about dilution and ongoing short interest.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors aggressively debate the sustainability of the current market rally, with many traders leveraging inverse ETFs to bet against perceived overvaluation in AI and semiconductor stocks. The community is actively divided between those bracing for a potential correction driven by geopolitical instability and those dismissing bearish sentiment as premature gambling.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

Direxion Daily MU Bull 2X Shares ($MUU) is surging as investors aggressively pile into Micron-linked leveraged plays to capture the ongoing memory super cycle and high-bandwidth memory (HBM) demand. The community is actively debating the merits of holding this leveraged ETF long-term versus day trading, with many participants citing analyst upgrades and long-term supply constraints as primary drivers for the bullish sentiment.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is facing intense debate as investors weigh its role as an AI and government infrastructure leader against broader software sector weakness. Community sentiment remains polarized, with vocal bulls focusing on long-term government contract potential and margin expansion, while skeptics are highlighting technical price breakdowns and concerns over market valuation relative to other high-profile tech plays.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending due to its relentless parabolic rally, with community sentiment split between those capitalizing on the massive momentum driven by AI storage demand and those bracing for an inevitable, brutal correction. Investors are intensely debating the sustainability of this once-in-a-generation price surge, with discussions dominated by comparisons to historical market bubbles and the impact of extreme short squeezes.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is trending as investors focus on its upcoming inclusion in the Russell 2000 Index and its strategic role in providing persistent memory for high-reliability aerospace, defense, and AI applications. Community discussions highlight a mix of bullish sentiment regarding potential SpaceX partnerships and government contracts versus caution over recent price volatility and persistent short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy

Mustang Bio surges 180% after its brain cancer therapy, MB-101, earns FDA Orphan Drug status for two rare brain tumor types.

Mustang Bio Ignites Bullish Retail Buzz As FDA Grants Orphan Status To Brain Cancer Drug

Equity

The company is advancing a novel combination of its CAR-T drug MB-101 and oncolytic virus MB-108, with both treatments currently enrolling patients in Phase 1 trials. 

Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off

From acquisition news and FDA designations to fresh optimism for struggling stocks, these biotechs piqued Stocktwits users the most on the first trading day of 2025.


Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Waltham, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '24	-$0.14	-$17.50	-12400.00%	MISSED
Q1 '24	-$0.46	--	--	N/A

MBIOMustang Bio Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '24

Historical Earnings

Latest MBIO News